Skip to main content

Table 1 Relationship between comorbidities and NUP37 or MCM2 expression in HCC patients (nā€‰=ā€‰300)

From: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

Variable

NUP37

MCM2

Low

High

p-value

Low

High

p-value

Hypertension

Ā No

153

71

0.338

159

65

0.121

Ā Yes

46

30

46

30

Diabetes

Ā No

183

89

0.384

187

85

0.787

Ā Yes

16

12

18

10

Liver cirrhosis

Ā No

176

93

0.233

185

84

0.781

Ā Yes

23

8

20

11

Fatty liver

Ā No

182

86

0.140

184

84

0.883

Ā Yes

17

15

21

11

Portal vein hypertension

Ā No

185

89

0.233

188

86

0.906

Ā Yes

14

12

17

9

Hepatitis B virus

Ā No

59

20

0.806

56

23

0.895

Ā Yes

160

61

153

68

  1. HCC, hepatocellular carcinoma